+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Penetrating Peptide Market Size, Share & Trends Analysis Report by Type (Protein Derived CPPs, Synthetic CPPs, Chimeric CPPs), Application (Drug Delivery, Gene Delivery), End-use (Hospitals & Clinics, CRO), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 180 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 5921038
Description Jump to:
The global cell penetrating peptide market size is expected to reach USD 2.85 billion by 2030, expandingat a CAGR of 10.08% from 2024 to 2030. Growing demand for targeted drug delivery methods is the primary factor propelling the growth. Technological advancements in chemical modification strategies & peptide synthesis techniques and increasing R&D activities to introduce precise therapeutics are increasing the demand for cell penetrating peptides in the market.

Moreover, rising approvals of novel drugs based on CPP technology is expected to offer lucrative opportunities for the key players during the study period. For instance, in September 2022, Revance Therapeutics, Inc. received U.S. Food and Drug Administration approval for DAXXIFY, which is developed based on cell-penetrating technology for temporary improvement of severe to moderate frown lines. This approval is projected to boost the market growth.

Advancements in the production processes of peptides are expected to drive the market. Manufacturers and suppliers are focused on developing new methods for synthesizing peptides, such as cell penetrating peptides. Improvement and automation of the purification process and lower waste generation are further increasing the demand for CPPs in different applications. For instance, in March 2022, Creative Peptides introduced innovative peptide drug discovery services to speed the development of peptide therapeutics, including CPPs therapies.

Growing funding for developing novel drugs to treat numerous diseases using cell penetrating peptides is anticipated to open new avenues for the market stakeholders. For instance, in September 2022, the Keck Graduate Institute received a research grant of USD 500,000 from the Foundation for Angelman Syndrome Therapeutics for two years to support research activities related to CPPs to targetAngelman Syndrome. Such initiatives are boosting the cell penetrating peptide sector growth.

However, cell penetrating peptides can certainly be synthesized on solid support using manual methods, and these can be tedious and time-intensive. The equipment for new systems can cost from USD 30,000 to USD 200,000 and above, depending on the synthesis scale capability & software. Hence, the high cost of manufacturing equipment may hamper the development of cell penetrating peptides by small players and emerging economies. On the other hand, continuous technological advancements are likely to boost the applications of CPPs during the forecast period.

Cell Penetrating Peptide Market Report Highlights

  • Based on type, the synthetic CPPs segment dominated the market in 2023 owing to their intrinsic property of delivering therapeutic molecules such as drugs, imaging agents, and nucleic acids
  • Based on application, the drug delivery segment held the largest segment share of the market in 2023, attributable to their low toxicity and efficiency of drug delivery into target cells
  • Based on end-use, the pharmaceutical & biotechnology companies segment led the market in 2023. It can be attributed to the rising utilization of peptides in pharmaceutical and biotechnology companies for R&D activities and the production of novel diagnostics and therapeutics
  • North America has established a strong regional position with a highest market share owing to the increasing funding for cell penetrating peptide research, favorable government policies, technological advancements, and the presence of key operating players in the region

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective - 1
1.2.2. Objective - 2
1.2.3. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. List Of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Type, Application, and End-use Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers
3.4.1. Technological Advancements of Peptide Synthesis
3.4.2. Growing Demand for Targeted Drug Delivery
3.4.3. Presence of Strong Pipeline
3.5. Market Restraint Analysis
3.5.1. Increasing Complexity of Peptides
3.5.2. High Cost of Manufacturing Equipment
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Cell Penetrating Peptide market: Type Movement Analysis
4.2. Protein Derived CPPs
4.2.1. Protein Derived CPPs Market, 2018-2030 (USD Million)
4.3. Synthetic CPPs
4.3.1. Synthetic CPPs Market, 2018-2030 (USD Million)
4.4. Chimeric CPPs
4.4.1. Chimeric CPPs Market, 2018-2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Cell Penetrating Peptide Market: Application Movement Analysis
5.2. Drug Delivery
5.2.1. Drug Delivery Market, 2018-2030 (USD Million)
5.3. Gene Delivery
5.3.1. Gene Delivery Market, 2018-2030 (USD Million)
5.4. Diagnostics
5.4.1. Diagnostics Market, 2018-2030 (USD Million)
5.5. Molecular Imaging
5.5.1. Molecular Imaging Market, 2018-2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018-2030 (USD Million)
Chapter 6. End-use Business Analysis
6.1. Cell Penetrating Peptide Market: End-use Movement Analysis
6.2. Pharmaceutical and Biotechnology Company
6.2.1. Pharmaceutical and Biotechnology Companies Market, 2018-2030 (USD Million)
6.3. Contract Research Organizations (CROs)
6.3.1. Contract Research Organizations (CROs) Market, 2018-2030 (USD Million)
6.4. Hospitals and Clinics
6.4.1. Hospitals and Clinics Market, 2018-2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018-2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Cell Penetrating Peptide Market Share By Region, 2023 & 2030
7.2. North America
7.2.1. North America Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Target Disease Prevalence
7.2.2.3. Competitive Scenario
7.2.2.4. Regulatory Framework
7.2.2.5. Reimbursement Scenario
7.2.2.6. U.S. Cell Penetrating Peptide market, 2018-2030 (USD MILLION)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Scenario
7.2.3.6. Canada Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.3. Europe
7.3.1. Europe Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. Regulatory Framework
7.3.2.5. Reimbursement Scenario
7.3.2.6. Germany Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Scenario
7.3.3.6. UK Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Scenario
7.3.4.6. France Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Scenario
7.3.5.6. Italy Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Scenario
7.3.6.6. Spain Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Scenario
7.3.7.6. Denmark Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Scenario
7.3.8.6. Sweden Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Scenario
7.3.9.6. Norway Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.4. Asia-Pacific
7.4.1. Asia-Pacific Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. Regulatory Framework
7.4.2.5. Reimbursement Scenario
7.4.2.6. Japan Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Scenario
7.4.3.6. China Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Scenario
7.4.4.6. India Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Scenario
7.4.5.6. South Korea Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Scenario
7.4.6.6. Australia Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Scenario
7.4.7.6. Thailand Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. Regulatory Framework
7.5.2.5. Reimbursement Scenario
7.5.2.6. Brazil Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Scenario
7.5.3.6. Mexico Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Scenario
7.5.4.6. Argentina Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.6. MEA
7.6.1. MEA Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Regulatory Framework
7.6.2.5. Reimbursement Scenario
7.6.2.6. South Africa Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Scenario
7.6.3.6. Saudi Arabia Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Scenario
7.6.4.6. UAE Cell Penetrating Peptide market, 2018-2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Scenario
7.6.5.6. Kuwait Cell Penetrating Peptide market, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant’s overview
8.2. Financial performance
8.3. Participant categorization
8.3.1. Market Leaders
8.3.2. Cell Penetrating Peptide market Share Analysis, 2023
8.3.3. Company Profiles
8.3.3.1. Pepscan
8.3.3.1.1. Company Overview
8.3.3.1.2. Financial Performance
8.3.3.1.3. Product Benchmarking
8.3.3.1.4. Strategic Initiatives
8.3.3.2. Creative Peptides
8.3.3.2.1. Company Overview
8.3.3.2.2. Financial Performance
8.3.3.2.3. Product Benchmarking
8.3.3.2.4. Strategic Initiatives
8.3.3.3. Cupidpeptides
8.3.3.3.1. Company Overview
8.3.3.3.2. Financial Performance
8.3.3.3.3. Product Benchmarking
8.3.3.3.4. Strategic Initiatives
8.3.3.4. AltaBioscience Ltd
8.3.3.4.1. Company Overview
8.3.3.4.2. Financial Performance
8.3.3.4.3. Product Benchmarking
8.3.3.4.4. Strategic Initiatives
8.3.3.5. AnaSpec
8.3.3.5.1. Company Overview
8.3.3.5.2. Financial Performance
8.3.3.5.3. Product Benchmarking
8.3.3.5.4. Strategic Initiatives
8.3.3.6. Peptomyc
8.3.3.6.1. Company Overview
8.3.3.6.2. Financial Performance
8.3.3.6.3. Product Benchmarking
8.3.3.6.4. Strategic Initiatives
8.3.3.7. BioAlps
8.3.3.7.1. Company Overview
8.3.3.7.2. Financial Performance
8.3.3.7.3. Product Benchmarking
8.3.3.7.4. Strategic Initiatives
8.3.3.8. Sarepta Therapeutics, Inc.
8.3.3.8.1. Company Overview
8.3.3.8.2. Financial Performance
8.3.3.8.3. Product Benchmarking
8.3.3.8.4. Strategic Initiatives
8.3.3.9. REVANCE THERAPEUTICS
8.3.3.9.1. Company Overview
8.3.3.9.2. Financial Performance
8.3.3.9.3. Product Benchmarking
8.3.3.9.4. Strategic Initiatives
8.3.3.10. Polypeptide Group
8.3.3.10.1. Company Overview
8.3.3.10.2. Financial Performance
8.3.3.10.3. Product Benchmarking
8.3.3.10.4. Strategic Initiatives
8.3.3.11. Bachem
8.3.3.11.1. Company Overview
8.3.3.11.2. Financial Performance
8.3.3.11.3. Product Benchmarking
8.3.3.11.4. Strategic Initiatives
8.3.4. Strategy Mapping
8.3.4.1. Expansion
8.3.4.2. Acquisition
8.3.4.3. Collaborations
8.3.4.4. Disease Type/Drug Class Launch
8.3.4.5. Partnerships
8.3.4.6. Others
List of Tables
Table 1 List of Abbreviations
Table 2 Global Cell Penetrating Peptide Market, by Region, 2018-2030 (USD Million)
Table 3 Global Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 4 Global Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 5 Global Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 6 North America Cell Penetrating Peptide Market, by Country, 2018-2030 (USD Million)
Table 7 North America Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 8 North America Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 9 North America Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 10 U.S. Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 11 U.S. Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 12 U.S. Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 13 Canada Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 14 Canada Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 15 Canada Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 16 Europe Cell Penetrating Peptide Market, by Country, 2018-2030 (USD Million)
Table 17 Europe Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 18 Europe Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 19 Europe Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 20 Germany Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 21 Germany Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 22 Germany Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 23 UK Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 24 UK Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 25 UK Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 26 France Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 27 France Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 28 France Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 29 Italy Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 30 Italy Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 31 Italy Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 32 Spain Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 33 Spain Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 34 Spain Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 35 Denmark Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 36 Denmark Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 37 Denmark Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 38 Sweden Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 39 Sweden Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 40 Sweden Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 41 Norway Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 42 Norway Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 43 Norway Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 44 Asia-Pacific Cell Penetrating Peptide Market, by Country, 2018-2030 (USD Million)
Table 45 Asia-Pacific Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 46 Asia-Pacific Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 47 Asia-Pacific Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 48 China Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 49 China Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 50 China Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 51 Japan Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 52 Japan Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 53 Japan Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 54 India Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 55 India Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 56 India Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 57 South Korea Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 58 South Korea Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 59 South Korea Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 60 Australia Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 61 Australia Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 62 Australia Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 63 Thailand Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 64 Thailand Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 65 Thailand Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 66 Latin America Cell Penetrating Peptide Market, by Country, 2018-2030 (USD Million)
Table 67 Latin America Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 68 Latin America Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 69 Latin America Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 70 Brazil Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 71 Brazil Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 72 Brazil Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 73 Mexico Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 74 Mexico Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 75 Mexico Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 76 Argentina Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 77 Argentina Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 78 Argentina Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 79 Middle East & Africa Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 80 Middle East & Africa Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 81 Middle East & Africa Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 82 Middle East & Africa Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 83 South Africa Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 84 South Africa Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 85 South Africa Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 86 Saudi Arabia Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 87 Saudi Arabia Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 88 Saudi Arabia Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 89 UAE Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 90 UAE Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 91 UAE Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
Table 92 Kuwait Cell Penetrating Peptide Market, by Type, 2018-2030 (USD Million)
Table 93 Kuwait Cell Penetrating Peptide Market, by Application, 2018-2030 (USD Million)
Table 94 Kuwait Cell Penetrating Peptide Market, By End-use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Cell Penetrating Peptide Market Segmentation
Figure 8 Market Snapshot, 2023
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Global Cell Penetrating Peptide Market: Disease Type Movement Analysis
Figure 15 Global Cell Penetrating Peptide Market, by Protein-Derived CPPs, 2018-2030 (USD Million)
Figure 16 Global Cell Penetrating Peptide Market, by Synthetic CPPs, 2018-2030 (USD Million)
Figure 17 Global Cell Penetrating Peptide Market, by Chimeric CPPs, 2018-2030 (USD Million)
Figure 18 Global Cell Penetrating Peptide Market: Application Movement Analysis
Figure 19 Global Cell Penetrating Peptide Market, by Drug Delivery, 2018-2030 (USD Million)
Figure 20 Global Cell Penetrating Peptide Market, by Gene Delivery 2018-2030 (USD Million)
Figure 21 Global Cell Penetrating Peptide Market, by Diagnostics, 2018-2030 (USD Million)
Figure 22 Global Cell Penetrating Peptide Market, by Molecular Imaging 2018-2030 (USD Million)
Figure 23 Global Cell Penetrating Peptide Market, by Others, 2018-2030 (USD Million)
Figure 24 Global Cell Penetrating Peptide Market: End-use Movement Analysis
Figure 25 Global Cell Penetrating Peptide Market, by Pharmaceutical and Biotechnology Company 2018-2030 (USD Million)
Figure 26 Global Cell Penetrating Peptide Market, by Contract Research Organization (CROs) 2018-2030 (USD Million)
Figure 27 Global Cell Penetrating Peptide Market, by Hospital and Clinics, 2018-2030 (USD Million)
Figure 28 Global Cell Penetrating Peptide Market, by Others, 2018-2030 (USD Million)
Figure 29 Regional Marketplace: Key Takeaways
Figure 30 Regional Outlook, 2023 & 2030
Figure 31 Global Cell Penetrating Peptide Market: Region Movement Analysis
Figure 32 North America Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 33 U.S. Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 34 Canada Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 35 Europe Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 36 Germany Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 37 UK Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 38 France Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 39 Italy Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 40 Spain Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 41 Denmark Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 42 Sweden Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 43 Norway Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 44 Asia-Pacific Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 45 Japan Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 46 China Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 47 India Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 48 Australia Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 49 South Korea Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 50 Thailand Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 51 Latin America Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 52 Brazil Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 53 Mexico Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 54 Argentina Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 55 Middle East and Africa Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 56 South Africa Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 57 Saudi Arabia Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 58 UAE Cell Penetrating Peptide Market, 2018-2030 (USD Million)
Figure 59 Kuwait Cell Penetrating Peptide Market, 2018-2030 (USD Million)

Companies Mentioned

  • Pepscan
  • Creative Peptides
  • Cupidpeptides
  • AltaBioscience Ltd
  • AnaSpec
  • Peptomyc
  • BioAlps
  • Sarepta Therapeutics, Inc.
  • REVANCE THERAPEUTICS
  • Polypeptide Group
  • Bachem

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedDecember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 1.47 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.85 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cell Penetrating Peptide Market Size, Share & Trends Analysis Report By End-use, By Application (Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging, and Others), By Type, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Cell Penetrating Peptide Market Size, Share & Trends Analysis Report By End-use, By Application (Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging, and Others), By Type, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 239 Pages
  • Global
From
Global Cell Penetrating Peptide Market Report 2024 - Product Image

Global Cell Penetrating Peptide Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Cell Culture Vessels Market Size, Share & Trends Analysis Report by Product (Bags, Flasks, Plates, Bottles, Dishes), Type (Reusable, Single-use), End-use (Pharmaceutical & Biotechnology Companies, CMOs & CROs), Region, and Segment Forecasts, 2025-2030 - Product Image

Cell Culture Vessels Market Size, Share & Trends Analysis Report by Product (Bags, Flasks, Plates, Bottles, Dishes), Type (Reusable, Single-use), End-use (Pharmaceutical & Biotechnology Companies, CMOs & CROs), Region, and Segment Forecasts, 2025-2030

  • Report
  • 140 Pages
  • Global
From
Contract Research Organization (CROs) Services Market by Type (Early Phase, Clinical, Lab, Consulting, Data Management), Therapeutic Area (Cancer, Infectious Disease, Neurology, Dermatology, Immunology, Hematology, Vaccines, CGT) - Forecast to 2029 - Product Image

Contract Research Organization (CROs) Services Market by Type (Early Phase, Clinical, Lab, Consulting, Data Management), Therapeutic Area (Cancer, Infectious Disease, Neurology, Dermatology, Immunology, Hematology, Vaccines, CGT) - Forecast to 2029

  • Report
  • 483 Pages
  • Global
From
Contract Research Organization (CRO) Services: Global Markets - Product Image

Contract Research Organization (CRO) Services: Global Markets

  • Report
  • 169 Pages
  • Global
From

About the Cell Penetrating Peptide Market

Cell Penetrating Peptides (CPPs) are short peptides that are used to facilitate the delivery of therapeutic molecules into cells. CPPs are used in biotechnology to deliver drugs, proteins, and nucleic acids into cells, allowing for the study of gene expression, protein-protein interactions, and other cellular processes. CPPs are also used in the development of novel therapeutics, such as gene therapy and cancer treatments. CPPs are typically synthesized using recombinant DNA technology, and can be modified to target specific cell types or tissues. CPPs are also used in the development of diagnostic tools, such as imaging agents and biosensors. The CPP market is growing rapidly, driven by increasing demand for novel therapeutics and diagnostic tools. The market is expected to benefit from advances in biotechnology, such as gene editing and synthetic biology. Companies in the CPP market include Bio-Synthesis, Inc., Creative Peptides, GenScript, and PolyPeptide Laboratories. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.